Zuri Murrell, MD
Colon & Rectal Surgery · Beverly Hills, CANPI 1881625267
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $58,695 of the $85,616 with a category attached, or 68.6%. 34 manufacturers reported payments, led by Novo Nordisk at 54.8% of the total. Among colon & rectal surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $276.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$47K
- Pfizer$15K
- Palette Life Sciences, Inc.$14K
- Biotissue Holdings Inc.$4K
- THD America, Inc.$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$776
- plus $3K from 28 others
What the payments were for
- Consulting fees$13,80016%
- Speaking & faculty fees$58,69569%
- Travel & lodging$4,1725%
- Food & beverage$8,87210%
- Education$370%
- Gifts$400%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 84 | $46,929 |
| Pfizer | 2 | $15,000 |
| Palette Life Sciences, Inc. | 18 | $14,358 |
| Biotissue Holdings Inc. | 28 | $3,690 |
| THD America, Inc. | 8 | $1,738 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 49 | $776 |
| Ferring Pharmaceuticals Inc. | 26 | $535 |
| Axonics, Inc. | 11 | $430 |
| Medtronic(2 entities) | 7 | $370 |
| Endo Pharmaceuticals Inc. | 17 | $304 |
| Teleflex LLC | 3 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $137 |
| Myriad Genetic Laboratories, Inc. | 5 | $135 |
| Lilly USA, LLC | 4 | $120 |
| Prescient Surgical | 6 | $117 |
| Intuitive Surgical | 3 | $115 |
| Exact Sciences | 4 | $96 |
| Merck | 4 | $64 |
| AstraZeneca | 4 | $60 |
| Braintree Laboratories, Inc. | 2 | $55 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Bausch Health US, LLC | 2 | $38 |
| Trevena, Inc. | 2 | $35 |
| Convatec Inc. | 1 | $34 |
| Vertex | 1 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Covidien LP | 1 | $23 |
| Innovation Technologies Inc | 1 | $23 |
| Olympus America Inc. | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $18 |
| Acell, Inc. | 1 | $17 |
| Shionogi Inc | 1 | $13 |
| Smith+Nephew | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$85,616 in reported general payments places this provider in the 95th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocortisone | 118 | $1,855 |
| Procto-Med HcHydrocortisone | 15 | $213 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Beverly Hills
- Stephen YooBeverly Hills$9K
- Sang LeeLos Angeles$2.4M
- Pamela LeeSan Diego$544K
- Elizabeth RaskinSacramento$126K
- Shohrat AnnaberdyevRoseville$101K
- Alessio PigazziLos Angeles$100K
- Joseph CarmichaelOrange$99K
- Phillip FleshnerWest Hollywood$95K
- Lorenc MalellariBakersfield$78K
- Ankit SarinSacramento$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.